
MJH Life Sciences
The largest independent, privately held medical media company in the US, owner of OncLive, NeurologyLive, Pharmacy Times, CURE, and more than a dozen specialty healthcare platforms.
Company Type
private
Founded
1999
Headquarters
Cranbury, New Jersey, USA
Revenue
Not publicly disclosed (private company; estimated in the hundreds of millions of dollars)
Employees
Approximately 1,000
Primary Market
United States
MJH Life Sciences Timeline
About MJH Life Sciences
What does MJH Life Sciences own?
MJH owns more than a dozen specialty medical media brands including OncLive, NeurologyLive, HCPLive, Pharmacy Times, CURE, ContagionLive, and Rare Disease Advisor, plus events and medical communications businesses.
Is MJH Life Sciences publicly traded?
No. MJH is privately held, led by the Hennessy family with private equity investment backing. It does not trade on any public exchange.
Who founded MJH Life Sciences?
Michael J. Hennessy Sr. founded the company in 1999, building on a family medical publishing career. His son, Mike Hennessy Jr., serves as chairman and CEO.
Where is MJH Life Sciences headquartered?
The company is headquartered in Cranbury, New Jersey, in the pharmaceutical corridor between New York and Philadelphia where many of its advertising clients are based.
How many brands does MJH Life Sciences own?
MJH operates more than a dozen specialty media properties across clinical disciplines, plus patient-facing, events, and medical communications businesses.
Who owns MJH Life Sciences?
The Hennessy family leads the company, with private equity investors holding a significant stake. Exact ownership percentages are not publicly disclosed.
History of MJH Life Sciences
The company is the continuation of a family medical publishing business. Michael J. Hennessy Sr. built his career in healthcare media and founded the predecessor entities of MJH in the late twentieth century, including medical publishing ventures that were predecessors to the modern company. MJH Life Sciences itself was established in 1999, consolidating the Hennessy family's medical media operations.
The strategic breakthrough was OncLive, launched as a digital oncology news platform at a time when medical news was still print-dominated. Its format, short video interviews with leading oncologists filmed at conferences, proved that clinicians would consume expert commentary online at scale, and it became the template for the company's expansion.
Through the 2000s and 2010s MJH replicated the model across specialties: Pharmacy Times for the pharmacy profession, CURE for cancer patients, HCPLive for general clinicians, and specialty verticals including NeurologyLive, launched around 2017 as neurology's drug pipeline and conference calendar expanded.
The company took private equity investment to fund growth, a common path in healthcare media, and has been reported in industry coverage as backed by financial sponsors while remaining Hennessy family led. Mike Hennessy Jr. succeeded his father as chairman and CEO, continuing the family leadership.
Through the early 2020s MJH expanded its events, custom media, and medical communications capabilities, and acquired complementary properties. As of November 2026 it remains privately held and independent, describing itself as the largest independent medical media company in America.
MJH Life Sciences Sustainability & Ethics
As a media company, MJH's material ethical issues are editorial rather than environmental. Its stated practices include separation between editorial content and sponsored programs, disclosure of sponsored content, and compliance with accreditation rules for continuing education. It holds no third-party certifications like B Corp.
The broader industry debate about pharmaceutical funding of medical media applies to MJH as much as to competitors, and the company addresses it through standard disclosure and editorial independence policies rather than structural separation.
Awards & Recognition
MJH and its brands regularly appear on healthcare media industry rankings and have received Digital Health Awards, medical publishing honors, and trade recognition for video journalism and conference coverage. OncLive in particular is frequently cited among the most-read oncology news sources in audience surveys.
Controversy, Regulation & Public Scrutiny
No major public controversies or regulatory actions against MJH Life Sciences are on record. The structural criticism applicable to the whole medical media sector, pharmaceutical advertising influence on editorial environments, is an industry-wide issue addressed through standard disclosure practices.
Brands Owned by MJH Life Sciences
MJH Life Sciences owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
MJH Life Sciences
private · Founded 1999 · Cranbury, New Jersey, USA
1
brands
MJH Life Sciences Ownership: Pros & Cons
Advantages
- +Family leadership continuity provides stable strategic direction
- +Private ownership allows long-term brand investment
- +Independent status differentiates it from conglomerate-owned competitors
- +Deep pharmaceutical industry relationships anchor revenue
- +Scalable platform model supports new specialty launches
Considerations
- -Private equity backing implies an eventual exit event
- -Revenue concentration in pharmaceutical advertising creates cyclicality
- -No public disclosure limits financial transparency
- -Competition from better-capitalized platforms like WebMD/Medscape persists
Frequently Asked Questions About MJH Life Sciences
What does MJH Life Sciences own?
MJH owns more than a dozen specialty medical media brands including OncLive, NeurologyLive, HCPLive, Pharmacy Times, CURE, ContagionLive, and Rare Disease Advisor, plus events and medical communications businesses.
Is MJH Life Sciences publicly traded?
No. MJH is privately held, led by the Hennessy family with private equity investment backing. It does not trade on any public exchange.
Who founded MJH Life Sciences?
Michael J. Hennessy Sr. founded the company in 1999, building on a family medical publishing career. His son, Mike Hennessy Jr., serves as chairman and CEO.
Where is MJH Life Sciences headquartered?
The company is headquartered in Cranbury, New Jersey, in the pharmaceutical corridor between New York and Philadelphia where many of its advertising clients are based.
How many brands does MJH Life Sciences own?
MJH operates more than a dozen specialty media properties across clinical disciplines, plus patient-facing, events, and medical communications businesses.
Who owns MJH Life Sciences?
The Hennessy family leads the company, with private equity investors holding a significant stake. Exact ownership percentages are not publicly disclosed.






